2型糖尿病心脏微血管并发症的研究
A Study of Cardiac Microvascular Complications in Type 2 Diabetes Mellitus
DOI: 10.12677/ACM.2023.1381846, PDF,   
作者: 宗 鑫：新疆医科大学第四临床医学院，新疆 乌鲁木齐；马 丽*：新疆维吾尔自治区中医院内分泌科，新疆 乌鲁木齐
关键词: 2型糖尿病；心脏微血管；并发症；研究进展；Type 2 Diabetes Mellitus； Cardiac Microvascular； Complications； Research Progress
摘要: 2型糖尿病微血管并发症不仅影响糖尿病患者生活质量与预期寿命，而且是导致糖尿病患者致死、致残的重要原因之一。2型糖尿病患者患心绞痛、射血分数保留性心力衰竭此类心脏微循环障碍疾病的风险增加。虽然这些疾病不是典型的糖尿病微血管并发症，但越来越多的证据表明，2型糖尿病微血管功能障碍是其关键的潜在机制之一。目前对2型糖尿病心脏微血管并发症的内容进行梳理总结，旨在为临床防治糖尿病及其微血管病变提供一定的参考依据。
Abstract: Microvascular complications of type 2 diabetes not only affect the quality of life and life expectancy of diabetic patients, but also are one of the important causes of death and disability in diabetic pa-tients. Patients with type 2 diabetes are at increased risk of cardiovascular microcirculatory disor-ders such as angina pectoris and ejection fraction retention heart failure. Although these disorders are not typical microvascular complications of diabetes, there is increasing evidence that micro-vascular dysfunction in type 2 diabetes is one of its key underlying mechanisms. At present, the content of type 2 diabetes heart microvascular complications is summarized, aiming to provide a certain reference for clinical prevention and treatment of diabetes and microvascular disease.
文章引用：宗鑫, 马丽. 2型糖尿病心脏微血管并发症的研究[J]. 临床医学进展, 2023, 13(8): 13214-13220. https://doi.org/10.12677/ACM.2023.1381846

参考文献

[1] Iatcu, C.O., Steen, A. and Covasa, M. (2021) Gut Microbiota and Complications of Type-2 Diabetes. Nutrients, 14, Arti-cle No. 166. [Google Scholar] [CrossRef] [PubMed]
[2] Qi, Y., Li, L., Feng, G., Shao, C., Cai, Y. and Wang, Z. (2021) Research Progress of Imaging Methods for Detection of Microvascular Angina Pectoris in Diabetic Patients. Frontiers in Cardiovascular Medicine, 8, Article ID: 713971. [Google Scholar] [CrossRef] [PubMed]
[3] 熊昕, 瞿华, 郑宏庭, 等. 线粒体氧化应激在糖尿病微血管并发症发病机制中的研究进展[J]. 中华内分泌代谢杂志, 2022, 38(7): 613-617. [Google Scholar] [CrossRef] 
[4] 王焰, 查云飞. 糖尿病微血管病变代谢组学研究进展[J]. 医学综述, 2022, 28(12): 2460-2464. [Google Scholar] [CrossRef] 
[5] Chowdhary, A., Thirunavukarasu, S., Jex, N., et al. (2022) Coronary Microvascular Function and Visceral Adiposity in Patients with Normal Body Weight and Type 2 Dia-betes. Obesity (Silver Spring), 30, 1079-1090. [Google Scholar] [CrossRef] [PubMed]
[6] Wei, Y., Ding, Q.Y., Yeung, C., et al. (2022) Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Adjuvant Treatment of Coronary Heart Disease in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. Journal of Diabetes Re-search, 2022, Article ID: 2545476. [Google Scholar] [CrossRef] [PubMed]
[7] 赵外荣, 张静, 施雯婷, 张凯玉, 马子霖, 马杰, 陈昕琳, 唐靖一, 周忠焱. 冠状动脉微血管疾病的发病机制及国内外治疗研究进展[J]. 世界中西医结合杂志, 2023, 18(3): 624-630.
[8] 邱惠, 李虹伟. 糖基化终末产物及其受体在动脉粥样硬化中的作用及意义[J]. 临床和实验医学杂志, 2018, 17(4): 443-446. [Google Scholar] [CrossRef] 
[9] 李艳杰, 褚瑜光, 倪青. 糖尿病性冠状动脉微血管病变致心肌梗死1例[J]. 中西医结合心脑血管病杂志, 2022, 20(5): 954-957.
[10] 徐索文, 葛均波, 翁建平. 内皮功能失调与泛血管疾病[J]. 中国科学技术大学学报, 2021, 51(8): 577-585.
[11] 海茹丽妮萨∙亚森, 于子翔, 马依彤. 射血分数保留型心力衰竭合并2型糖尿病的研究进展[J]. 中国心血管病研究, 2021, 19(3): 274-278.
[12] Knapp, M., Tu, X. and Wu, R. (2019) Vascular Endothelial Dysfunction, a Major Mediator in Di-abetic Cardiomyopathy. Acta Pharmacologica Sinica, 40, 1-8. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, E., Wang, H. and Chakrabarti, S. (2023) Endotheli-al-to-Mesenchymal Transition: An Underappreciated Mediator of Diabetic Complications. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1050540. [Google Scholar] [CrossRef] [PubMed]
[14] Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., et al. (2022) Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Thera-peutic Options. Biomedicines, 10, Article No. 2274. [Google Scholar] [CrossRef] [PubMed]
[15] Clyne, A.M. (2021) Endothelial Response to Glucose: Dys-function, Metabolism, and Transport. Biochemical Society Transactions, 49, 313-325. [Google Scholar] [CrossRef] 
[16] Liu, J. and Liu, Z. (2019) Muscle Insulin Resistance and the Inflamed Microvasculature: Fire from within. International Journal of Molecular Sciences, 20, Article No. 562. [Google Scholar] [CrossRef] [PubMed]
[17] 葛均波, 翁建平, 曾强. 2型糖尿病患者泛血管疾病风险评估与管理中国专家共识(2022版) [J]. 中国循环杂志, 2022, 37(10): 974-990.
[18] 刘笑迎, 邵静. 冠状动脉微血管功能障碍危险因素的研究进展[J]. 中国心血管病研究, 2023, 21(4): 289-293.
[19] Bajaj, N.S., Osborne, M.T., Gupta, A., et al. (2018) Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. Journal of the American College of Cardiology, 72, 707-717. [Google Scholar] [CrossRef] [PubMed]
[20] Godo, S., Takahashi, J., Yasuda, S. and Shimokawa, H. (2021) Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction. European Cardiology, 16, e13. [Google Scholar] [CrossRef] [PubMed]
[21] Kaski, J.C., Crea, F., Gersh, B.J. and Camici, P.G. (2018) Reappraisal of Ischemic Heart Disease. Circulation, 138, 1463-1480. [Google Scholar] [CrossRef] 
[22] Aldiwani, H., Mahdai, S., Alhatemi, G. and Bairey Merz, C.N. (2021) Microvascular Angina: Diagnosis and Management. European Cardiology, 16, e46. [Google Scholar] [CrossRef] [PubMed]
[23] 聂祥, 樊佳慧, 陈琛, 汪道文. 冠状动脉微血管功能障碍与心脏病[J]. 中国科学: 生命科学, 2022, 52(5): 748-759.
[24] Gamrat, A., Surdacki, M.A., Chyrchel, B. and Surdacki, A. (2020) Endothelial Dysfunction: A Contributor to Adverse Cardiovascular Remodeling and Heart Failure Development in Type 2 Diabetes beyond Accelerated Atherogenesis. Journal of Clinical Medicine, 9, Article No. 2090. [Google Scholar] [CrossRef] [PubMed]
[25] Vancheri, F., Longo, G., Vancheri, S. and Henein, M. (2020) Coronary Microvascular Dysfunction. Journal of Clinical Medicine, 9, Article No. 2880. [Google Scholar] [CrossRef] [PubMed]
[26] Rush, C.J., Berry, C., Oldroyd, K.G., et al. (2021) Prevalence of Coro-nary Artery Disease and Coronary Microvascular Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction. JAMA Cardiology, 6, 1130-1143. [Google Scholar] [CrossRef] [PubMed]
[27] 杨燕, 卓见, 申红霞, 韩瑞敏, 王珍, 王德峰. 新型降糖药物治疗2型糖尿病的研究进展[J]. 实用医学杂志, 2023, 39(2): 153-157.
[28] Nilsson, M., Bové, K.B., Suhrs, E., et al. (2019) The Effect of DPP-4-Protected GLP-1 (7-36) on Coronary Microvascular Function in Obese Adults. Interna-tional Journal of Cardiology, Heart & Vasculature, 22, 139-144. [Google Scholar] [CrossRef] [PubMed]
[29] Tu, Y., Li, Q., Zhou, Y., et al. (2022) Empagliflozin Inhibits Cor-onary Microvascular Dysfunction and Reduces Cardiac Pericyte Loss in db/db Mice. Frontiers in Cardiovascular Medi-cine, 9, Article ID: 995216. [Google Scholar] [CrossRef] [PubMed]
[30] 胡金明, 钟萍. 高血压患者冠状动脉微循环损伤研究进展[J]. 实用医院临床杂志, 2020, 17(5): 234-236.
[31] 张茜, 任媛, 李思进. 糖尿病合并冠状动脉微血管功能障碍的研究进展[J]. 中国医药, 2021, 16(2): 309-312.
[32] 石鑫, 修春红, 王琳鑫, 翟瑗媛, 陈媛, 曾令泽, 毕亚艳. 冠状动脉微循环疾病的病理生理机制及其治疗方法[J]. 心血管康复医学杂志, 2021, 30(1): 71-75.
[33] Xiong, J., Hu, H., Guo, R., Wang, H. and Jiang, H. (2021) Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Dia-betes Complications. Frontiers in Endocrinology (Lausanne), 12, Article ID: 646233. [Google Scholar] [CrossRef] [PubMed]
[34] 李红蓉, 秘红英, 孙颖, 等. 基于脉络学说对动脉粥样硬化病因病机的认识[J]. 中医杂志, 2017, 58(16): 1359-1363, 1367. [Google Scholar] [CrossRef] 
[35] 冯宇. 心之络病-孙络瘀阻的中医微观病理特征研究[D]: [博士学位论文]. 北京: 中国人民解放军医学院, 2019.
[36] 曾娟花, 沈艳, 唐红, 等. 泄浊降脂片对2型糖尿病痰瘀证患者炎性细胞因子的影响[J]. 吉林中医药, 2020, 40(5): 631-634. [Google Scholar] [CrossRef] 
[37] 陈子琪, 吴姿莹, 彭璘, 等. 糖尿病肾病的中医“虚、瘀、浊”理论与Wnt/β-catenin信号通路的相关性[J]. 中国民族民间医药, 2022, 31(18): 20-23.
[38] 魏凯善, 魏静, 罗敏, 等. 从“玄府-浊毒-络脉”角度再识糖尿病及其微血管并发症[J]. 中国中医基础医学杂志, 2020, 26(6): 731-733, 795. [Google Scholar] [CrossRef] 
[39] 柯爽, 李小娟. 从络论治消渴胸痹[J]. 实用中医内科杂志, 2020, 34(3): 108-111. [Google Scholar] [CrossRef] 
[40] 吴进, 王子龙, 张忠勇, 等. 从郁、瘀、痰、浊论糖尿病微血管病变中医病因病机[J]. 中医药临床杂志, 2019, 31(11): 1997-1999. [Google Scholar] [CrossRef] 
[41] 韦伟, 徐巧玲, 石丽威, 等. 尼可地尔联合通心络治疗老年冠状动脉慢血流患者的临床研究[J]. 中国临床保健杂志, 2022, 25(4): 507-510. [Google Scholar] [CrossRef] 
[42] 明亮, 邵正斌. 邵正斌运用益气养阴、化痰通络方治疗冠脉微循环障碍合并糖尿病经验[J]. 中医药临床杂志, 2021, 33(4): 627-630.
[43] 佘令正, 李鸿真, 杨洁, 等. 林慧娟教授辨治冠状动脉微血管功能障碍经验[J]. 中国中医急症, 2022, 31(12): 2211-2214.

为你推荐